Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Nervous System Disorders

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Nervous System Disorders in 2 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Louin, G1
Marchand-Verrecchia, C1
Palmier, B1
Plotkine, M1
Jafarian-Tehrani, M1
Chabrier, PE1
Demerlé-Pallardy, C1
Auguet, M1

Reviews

1 review available for n-(3-(aminomethyl)benzyl)acetamidine and Nervous System Disorders

ArticleYear
Nitric oxide synthases: targets for therapeutic strategies in neurological diseases.
    Cellular and molecular life sciences : CMLS, 1999, Volume: 55, Issue:8-9

    Topics: Alzheimer Disease; Amidines; Amyotrophic Lateral Sclerosis; Animals; Benzylamines; Brain Injuries; B

1999

Other Studies

1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Nervous System Disorders

ArticleYear
Selective inhibition of inducible nitric oxide synthase reduces neurological deficit but not cerebral edema following traumatic brain injury.
    Neuropharmacology, 2006, Volume: 50, Issue:2

    Topics: Amidines; Animals; Benzylamines; Blood-Brain Barrier; Body Water; Brain Edema; Brain Injuries; Enzym

2006
chemdatabank.com